Curis, Inc. (CRIS) vs Alaunos Therapeutics, Inc. (TCRT)
A side-by-side comparison of Curis, Inc. and Alaunos Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRIS
Curis, Inc.
$0.76HealthcareDelayed quote: Oct 6, 2026, 3:09 PM EDT
TCRT
Alaunos Therapeutics, Inc.
$0.73HealthcareDelayed quote: Oct 6, 2026, 3:03 PM EDT
Total return — CRIS vs TCRT
growth of $100 · dividends reinvested · last 10yCRIS -100.0% (-59.1%/yr)TCRT -99.9% (-50.0%/yr)TCRT compounded faster over this window
Log scale — wide-divergence pair
CRIS TCRT
CRIS vs TCRT: by the numbers
- •TCRT is the larger company ($2M vs $1M market cap).
- •Both run net losses; CRIS's is the smaller (-490.33% vs -133666.67% net margin).
Metrics side by side
Valuation
| Metric | CRIS | TCRT |
|---|---|---|
| P/S ratio | 0.34 | 595.80 |
| P/B ratio | 0.32 | 2.74 |
Profitability
| Metric | CRIS | TCRT |
|---|---|---|
| Gross margin | 99.28% | -27160.00% |
| Operating margin | -348.43% | -84500.00% |
| Net margin | -490.33% | -133666.67% |
| ROE | -450.54% | -615.03% |
| ROIC | -567.17% | -622.39% |
Growth (annualized)
| Metric | CRIS | TCRT |
|---|---|---|
| Revenue CAGR (5Y) | -15.88% | N/A |
| Total return CAGR (5Y) | -81.06% | -69.13% |
Frequently asked
- How have CRIS and TCRT total returns compared?
- Over the past 10 years, CRIS delivered -59.09% and TCRT delivered -50.22% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.